COSMOS Pharmaceutical Corporation(3349) News

Notice Concerning Organizational and Personnel Changes

Consolidated Financial Results for the Six Months Ended November 30, 2025[Japanese GAAP]

COSMOS Pharma, First Half Ordinary Profit Increases by 1%, Sep-Nov Ordinary Profit Increases by 3%

Consolidated Financial Results for the Three Months Ended August 31, 2025[Japanese GAAP]

COSMOS Pharma, Jun-Aug (1Q) Ordinary Profit Decreases by 1%

View and Policy on Reduction of Investment Unit

Notice Concerning Changes in Directors

Notice Concerning Distribution of Dividends of Surplus

Consolidated Financial Results for the Fiscal Year Ended May 31, 2025[Japanese GAAP]

COSMOS Pharma, 0.1％ Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Increased Previous Year's Dividend by 5 Yen, This Fiscal Year to Increase Dividend by 5 Yen

[Summary]Consolidated Financial Results for the Nine Months Ended February 28, 2025[Japanese GAAP]

COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 30%, Dec-Feb Ordinary Profit Increases by 40%

（Correction）Consolidated Financial Results for the Six Months Ended November 30, 2024[Japanese GAAP]

Consolidated Financial Results for the Six Months Ended November 30, 2024[Japanese GAAP]

COSMOS Pharma, First Half Ordinary Profit Increases by 26%

COSMOS Pharmaceutical Corporation, June-August (1Q) Ordinary Profit Increases by 27%

Consolidated Financial Results for the Three Months Ended August 31, 2024[Japanese GAAP]